140 related articles for article (PubMed ID: 32579550)
61. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
[TBL] [Abstract][Full Text] [Related]
62. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
63. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
64. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
[TBL] [Abstract][Full Text] [Related]
65. A transcriptome-based model of central memory CD4 T cell death in HIV infection.
Olvera-García G; Aguilar-García T; Gutiérrez-Jasso F; Imaz-Rosshandler I; Rangel-Escareño C; Orozco L; Aguilar-Delfín I; Vázquez-Pérez JA; Zúñiga J; Pérez-Patrigeon S; Espinosa E
BMC Genomics; 2016 Nov; 17(1):956. PubMed ID: 27875993
[TBL] [Abstract][Full Text] [Related]
66. The predictive role of CD4
Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
[TBL] [Abstract][Full Text] [Related]
67. HIV-1 subtypes and response to combination antiretroviral therapy in Europe.
Bannister WP; Ruiz L; Loveday C; Vella S; Zilmer K; Kjaer J; Knysz B; Phillips AN; Mocroft A;
Antivir Ther; 2006; 11(6):707-15. PubMed ID: 17310815
[TBL] [Abstract][Full Text] [Related]
68. Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive highly active antiretroviral therapy.
Bai F; Bellistrì GM; Tincati C; Savoldi A; Pandolfo A; Bini T; Carpani G; Sinigaglia E; Marchetti G; d'Arminio Monforte A
AIDS; 2010 Oct; 24(16):2590-3. PubMed ID: 20935556
[TBL] [Abstract][Full Text] [Related]
69. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
[TBL] [Abstract][Full Text] [Related]
70. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
[TBL] [Abstract][Full Text] [Related]
71. An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers.
Ding J; Ma L; Zhao J; Xie Y; Zhou J; Li X; Cen S
J Transl Med; 2019 Jan; 17(1):35. PubMed ID: 30665429
[TBL] [Abstract][Full Text] [Related]
72. Elevated Expression of miR-19b Enhances CD8
Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
Front Immunol; 2018; 9():3140. PubMed ID: 30687333
[TBL] [Abstract][Full Text] [Related]
73. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.
Seminari E; Tinelli C; Ravasi G; Ripamonti D; Ladisa N; Marino N; Sighinolfi L; Mondello P; Migliorino M; Carosi G; Maserati R;
Curr HIV Res; 2010 Apr; 8(3):186-93. PubMed ID: 20163342
[TBL] [Abstract][Full Text] [Related]
74. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
[TBL] [Abstract][Full Text] [Related]
75. Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.
Songok EM; Luo M; Liang B; Mclaren P; Kaefer N; Apidi W; Boucher G; Kimani J; Wachihi C; Sekaly R; Fowke K; Ball BT; Plummer FA
PLoS One; 2012; 7(1):e30048. PubMed ID: 22291902
[TBL] [Abstract][Full Text] [Related]
76. Differential gene expression in HIV-infected individuals following ART.
Massanella M; Singhania A; Beliakova-Bethell N; Pier R; Lada SM; White CH; Pérez-Santiago J; Blanco J; Richman DD; Little SJ; Woelk CH
Antiviral Res; 2013 Nov; 100(2):420-8. PubMed ID: 23933117
[TBL] [Abstract][Full Text] [Related]
77. Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection.
Wan LY; Huang HH; Zhen C; Chen SY; Song B; Cao WJ; Shen LL; Zhou MJ; Zhang XC; Xu R; Fan X; Zhang JY; Shi M; Zhang C; Jiao YM; Song JW; Wang FS
Emerg Microbes Infect; 2023 Dec; 12(1):2150566. PubMed ID: 36408648
[TBL] [Abstract][Full Text] [Related]
78. Distinct immune profiles of HIV-infected subjects are linked to specific lipid mediator signature.
Sips M; Gerlo S; De Clercq L; Gomez EA; Colas RA; Dalli J; Vandekerckhove L
Immun Inflamm Dis; 2022 Jun; 10(6):e629. PubMed ID: 35634953
[TBL] [Abstract][Full Text] [Related]
79. Peripheral blood RNA expression profiling in illicit methcathinone users reveals effect on immune system.
Sikk K; Kõks S; Soomets U; Schalkwyk LC; Fernandes C; Haldre S; Aquilonius SM; Taba P
Front Genet; 2011; 2():42. PubMed ID: 22303338
[TBL] [Abstract][Full Text] [Related]
80. Correction: Single-cell sequencing resolves the landscape of immune cells and regulatory mechanisms in HIV-infected immune non-responders.
Li H; Tang Y; Wang Y; Li Y; Yang Y; Liao K; Song F; Deng S; Chen Y
Cell Death Dis; 2023 Jul; 14(7):416. PubMed ID: 37438335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
